Market revenue in 2023 | USD 488.0 million |
Market revenue in 2030 | USD 2,297.7 million |
Growth rate | 24.8% (CAGR from 2023 to 2030) |
Largest segment | Pcr technology |
Fastest growing segment | NGS Technology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies |
Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 27.42% in 2023. Horizon Databook has segmented the Australia synthetic biology market based on ngs technology, pcr technology, genome editing technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Strong support from government and nongovernment organizations is expected to drive the demand for synthetic biology in Australia. For instance, Synthetic Biology Australasia (SBA) is a nonprofit community to support growing research in synthetic biology in New Zealand, Australia, and the broader Australasian region.
It promotes collaborations within academia and between academia &industry. Moreover, it engaged in education, public outreach, and training in synthetic biology. Moreover, CSIR Synthetic Biology Future Science Platform (FSP) plays a role in the growth of synthetic biology in Australia.
Synthetic biology is expected to transform existing industries and create novel business for Australia in industrial biotechnology, health, and agriculture. Moreover, increasing funding for synthetic biology in Australia is expected to drive market growth in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia synthetic biology market , including forecasts for subscribers. This country databook contains high-level insights into Australia synthetic biology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account